|
E2F8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.78619999966234E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.95130003663746E-09 |
| Normal-vs-Stage2 |
2.537100E-03 |
| Normal-vs-Stage3 |
1.71834000000093E-05 |
| Normal-vs-Stage4 |
6.015400E-03 |
| Stage1-vs-Stage2 |
3.465800E-01 |
| Stage1-vs-Stage3 |
3.596100E-03 |
| Stage1-vs-Stage4 |
3.514000E-02 |
| Stage2-vs-Stage3 |
4.579000E-03 |
| Stage2-vs-Stage4 |
5.055800E-02 |
| Stage3-vs-Stage4 |
9.104800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18719486966279E-11 |
| Normal-vs-AfricanAmerican |
1.14309999998952E-06 |
| Normal-vs-Asian |
2.258300E-02 |
| Caucasian-vs-AfricanAmerican |
1.605230E-01 |
| Caucasian-vs-Asian |
1.357940E-02 |
| AfricanAmerican-vs-Asian |
8.428400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01407771069262E-12 |
| Normal-vs-Female |
3.273600E-02 |
| Male-vs-Female |
3.352000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.182020E-04 |
| Normal-vs-Extreme_Weight |
2.44949999950173E-07 |
| Normal-vs-Obese |
1.7617000003245E-07 |
| Normal-vs-Extreme_Obese |
3.729600E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.082200E-01 |
| Normal_Weight-vs-Obese |
5.796400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.896700E-03 |
| Extreme_Weight-vs-Obese |
6.417700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.732370E-02 |
| Obese-vs-Extreme_Obese |
4.444900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.595000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.08889564032211E-11 |
| Normal-vs-Age(61-80Yrs) |
4.25089999978034E-07 |
| Normal-vs-Age(81-100Yrs) |
8.664300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.984100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.880000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.682700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.911580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.597700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.863040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.70899969123661E-11 |
| Normal-VS-Type2 PRCC |
2.54089999995877E-06 |
| Normal-VS-KIRP CIMP |
7.441000E-04 |
| Normal-VS-Unclassified PRCC |
1.046010E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.749800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.354700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.294150E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.716300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.202400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.973900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73112999999336E-05 |
| Normal-vs-N1 |
3.50589999997819E-06 |
| Normal-vs-N2 |
1.75159999837859E-08 |
| N0-vs-N1 |
2.418500E-03 |
| N0-vs-N2 |
6.680200E-01 |
| N1-vs-N2 |
2.167900E-02 |
|
|
